相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Polyglutamine diseases
Emma L. Bunting et al.
CURRENT OPINION IN NEUROBIOLOGY (2022)
The CRISPR-Cas toolbox and gene editing technologies
Guanwen Liu et al.
MOLECULAR CELL (2022)
History of genome editing: From meganucleases to CRISPR
Simon E. Troeder et al.
LABORATORY ANIMALS (2022)
Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias
Marina P. Hommersom et al.
STEM CELL REVIEWS AND REPORTS (2022)
Wide range of reduced penetrance alleles in spinal and bulbar muscular atrophy: a model-based approach
Achilleas Laskaratos et al.
JOURNAL OF MEDICAL GENETICS (2021)
Precise CAG repeat contraction in a Huntington's Disease mouse model is enabled by gene editing with SpCas9-NG
Seiya Oura et al.
COMMUNICATIONS BIOLOGY (2021)
Frequency of spinocerebellar ataxia mutations in patients with multiple system atrophy
Anna I. Wernick et al.
CLINICAL AUTONOMIC RESEARCH (2021)
Human stem cell models of polyglutamine diseases: Sources for disease models and cell therapy
Lang He et al.
EXPERIMENTAL NEUROLOGY (2021)
Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies
K. R. Sabitha et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)
A high-throughput screening to identify small molecules that suppress huntingtin promoter activity or activate huntingtin-antisense promoter activity
Houda G. Khaled et al.
SCIENTIFIC REPORTS (2021)
Propensity for somatic expansion increases over the course of life in Huntington disease
Radhia Kacher et al.
ELIFE (2021)
Paving the way towards precise and safe CRISPR genome editing
Pawel Sledzinski et al.
BIOTECHNOLOGY ADVANCES (2021)
Flow cytometry allows rapid detection of protein aggregates in cellular and zebrafish models of spinocerebellar ataxia 3
Katherine J. Robinson et al.
DISEASE MODELS & MECHANISMS (2021)
Genetic Modeling of the Neurodegenerative Disease Spinocerebellar Ataxia Type 1 in Zebrafish
Mohamed A. Elsaey et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Points of View on the Tools for Genome/Gene Editing
Chin-Kai Chuang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
CRISPR/Cas based gene editing: marking a new era in medical science
Kirti Prasad et al.
MOLECULAR BIOLOGY REPORTS (2021)
Molecular mechanisms underlying nucleotide repeat expansion disorders
Indranil Malik et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
A phenolic-rich extract from Ugni molinae berries reduces abnormal protein aggregation in a cellular model of Huntington's disease
Rodrigo Perez-Arancibia et al.
PLOS ONE (2021)
CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells
Lang He et al.
TRANSLATIONAL PSYCHIATRY (2021)
On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability
Alexandra N. Khristich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Lack of RAN-mediated toxicity in Huntington's disease knock-in mice
Su Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Recent Overview of the Use of iPSCs Huntington's Disease Modeling and Therapy
Maria Csobonyeiova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology
Magdalena Dabrowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form
Huiming Yang et al.
NATURE COMMUNICATIONS (2020)
Co-chaperones DNAJA1 and DNAJB6 are critical for regulation of polyglutamine aggregation
Claudio Rodriguez-Gonzalez et al.
SCIENTIFIC REPORTS (2020)
Review Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening
Chia-Yu Chang et al.
MOLECULES (2020)
Linking epigenetic dysregulation, mitochondrial impairment, and metabolic dysfunction in SBMA motor neurons
Naemeh Pourshafie et al.
JCI INSIGHT (2020)
Large Animal Models in Regenerative Medicine and Tissue Engineering: To Do or Not to Do
Iris Ribitsch et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
The contribution ofC. elegansneurogenetics to understanding neurodegenerative diseases
Joseph J. H. Liang et al.
JOURNAL OF NEUROGENETICS (2020)
Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks
Han Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Generation of Common Marmoset Model Lines of Spinocerebellar Ataxia Type 3
Ikuo Tomioka et al.
FRONTIERS IN NEUROSCIENCE (2020)
INDEL detection, the 'Achilles heel' of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels
Eric Paul Bennett et al.
NUCLEIC ACIDS RESEARCH (2020)
A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington's Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities
Tuyana Malankhanova et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
The Neurodevelopmental Hypothesis of Huntington's Disease
Ellen van der Plas et al.
JOURNAL OF HUNTINGTONS DISEASE (2020)
Large Animal Models of Huntington's Disease: What We Have Learned and Where We Need to Go Next
David Howland et al.
JOURNAL OF HUNTINGTONS DISEASE (2020)
ATXN2 intermediate repeat expansions influence the clinical phenotype in frontotemporal dementia
Elisa Rubino et al.
NEUROBIOLOGY OF AGING (2019)
Creating cell and animal models of human disease by genome editing using CRISPR/Cas9
Ali Zarei et al.
JOURNAL OF GENE MEDICINE (2019)
Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects
Jolene Ooi et al.
CELL REPORTS (2019)
Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
Ronald A. M. Buijsen et al.
NEUROTHERAPEUTICS (2019)
Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells
Swati Naphade et al.
NEUROTHERAPEUTICS (2019)
Striatal Interneurons in Transgenic Nonhuman Primate Model of Huntington's Disease
Shoeb B. Lallani et al.
SCIENTIFIC REPORTS (2019)
A Huntingtin Knockin Pig Model Recapitulates Features of Selective Neurodegeneration in Huntington's Disease
Sen Yan et al.
CELL (2018)
Chromosomal instability during neurogenesis in Huntington's disease
Albert Ruzo et al.
DEVELOPMENT (2018)
Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes
P. Conforti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
Ronen Ben Jehuda et al.
STEM CELL REVIEWS AND REPORTS (2018)
CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived iPSCs
Shuming Ouyang et al.
STEM CELLS AND DEVELOPMENT (2018)
Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
Ronen Ben Jehuda et al.
STEM CELL REVIEWS AND REPORTS (2018)
Precise Excision of the CAG Tract from the Huntingtin Gene by Cas9 Nickases
Magdalena Dabrowska et al.
FRONTIERS IN NEUROSCIENCE (2018)
Polyglutamine Repeats in Neurodegenerative Diseases
Andrew P. Lieberman et al.
Annual Review of Pathology-Mechanisms of Disease (2018)
A patient-derived cellular model for Huntington's disease reveals phenotypes at clinically relevant CAG lengths
Claudia Lin-Kar Hung et al.
MOLECULAR BIOLOGY OF THE CELL (2018)
Mitochondrial alterations accompanied by oxidative stress conditions in skin fibroblasts of Huntington's disease patients
Paulina Jedrak et al.
METABOLIC BRAIN DISEASE (2018)
Introducing an expanded CAG tract into the huntingtin gene causes a wide spectrum of ultrastructural defects in cultured human cells
Ksenia N. Morozova et al.
PLOS ONE (2018)
Directed evolution of CRISPR-Cas9 to increase its specificity
Jungjoon K. Lee et al.
NATURE COMMUNICATIONS (2018)
Neuronal cell culture from transgenic zebrafish models of neurodegenerative disease
Jamie R. Acosta et al.
BIOLOGY OPEN (2018)
Studying Huntington's Disease in Yeast: From Mechanisms to Pharmacological Approaches
Sebastian Hofer et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease
Nivya Kolli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease
Su Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Bridging the gap: large animal models in neurodegenerative research
S. L. Eaton et al.
MAMMALIAN GENOME (2017)
CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
Alex Mas Monteys et al.
MOLECULAR THERAPY (2017)
Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges
Anna Poon et al.
NEW BIOTECHNOLOGY (2017)
Spatiotemporal Proteomic Profiling of Huntington's Disease Inclusions Reveals Widespread Loss of Protein Function
Fabian Hosp et al.
CELL REPORTS (2017)
Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells
Xiaohong Xu et al.
STEM CELL REPORTS (2017)
In Situ Architecture and Cellular Interactions of PolyQ Inclusions
Felix J. B. Baeuerlein et al.
CELL (2017)
Modern Genome Editing Technologies in Huntington's Disease Research
Tuyana B. Malankhanova et al.
JOURNAL OF HUNTINGTONS DISEASE (2017)
Transgenic Monkey Model of the Polyglutamine Diseases Recapitulating Progressive Neurological Symptoms
Ikuo Tomioka et al.
ENEURO (2017)
In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy
Maria Pennuto et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2016)
Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation
K. Seidel et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2016)
Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts
Kyle D. Fink et al.
CELL TRANSPLANTATION (2016)
Modeling simple repeat expansion diseases with iPSC technology
Edyta Jaworska et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9
Jun Wan Shin et al.
HUMAN MOLECULAR GENETICS (2016)
Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis
Guohao Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H271
Adele G. Marthaler et al.
STEM CELL RESEARCH (2016)
Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H196
Adele G. Marthaler et al.
STEM CELL RESEARCH (2016)
Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H266
Adele G. Marthaler et al.
STEM CELL RESEARCH (2016)
Contracting CAG/CTG repeats using the CRISPR-Cas9 nickase
Cinzia Cinesi et al.
NATURE COMMUNICATIONS (2016)
N-terminal Huntingtin Knock-In Mice: Implications of Removing the N-terminal Region of Huntingtin for Therapy
Xudong Liu et al.
PLOS GENETICS (2016)
Motor Dysfunctions and Neuropathology in Mouse Models of Spinocerebellar Ataxia Type 2: A Comprehensive Review
Joao M. Da Conceicao Alves-Cruzeiro et al.
FRONTIERS IN NEUROSCIENCE (2016)
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Bernd Zetsche et al.
CELL (2015)
Studying polyglutamine diseases in Drosophila
Zhen Xu et al.
EXPERIMENTAL NEUROLOGY (2015)
A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD
Pawel M. Switonski et al.
NEUROBIOLOGY OF DISEASE (2015)
Mouse polyQ database: a new online resource for research using mouse models of neurodegenerative diseases
Wojciech J. Szlachcic et al.
MOLECULAR BRAIN (2015)
A two years longitudinal study of a transgenic Huntington disease monkey
Anthony W. S. Chan et al.
BMC NEUROSCIENCE (2014)
Evidence-based genetic counselling implications for Huntington disease intermediate allele predictive test results
A. Semaka et al.
CLINICAL GENETICS (2014)
Mind the Gap: Models in Multiple Species Needed for Therapeutic Development in Huntington's Disease
David S. Howland et al.
MOVEMENT DISORDERS (2014)
Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients
Christopher Grunseich et al.
NEUROBIOLOGY OF DISEASE (2014)
Targeted genome modification technologies and their applications in crop improvements
Kunling Chen et al.
PLANT CELL REPORTS (2014)
Highly Specific Contractions of a Single CAG/CTG Trinucleotide Repeat by TALEN in Yeast
Guy-Franck Richard et al.
PLOS ONE (2014)
Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: Implication in a loss-of-function pathology
Hui Yang et al.
SCIENTIFIC REPORTS (2014)
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Lei S. Qi et al.
CELL (2013)
A TALEN Genome-Editing System for Generating Human Stem Cell-Based Disease Models
Qiurong Ding et al.
CELL STEM CELL (2013)
Genome editing of human pluripotent stem cells to generate human cellular disease models
Kiran Musunuru
DISEASE MODELS & MECHANISMS (2013)
Enhanced Aggregation of Androgen Receptor in Induced Pluripotent Stem Cell-derived Neurons from Spinal and Bulbar Muscular Atrophy
Yoshihiro Nihei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Generation of Human-Induced Pluripotent Stem Cells to Model Spinocerebellar Ataxia Type 2 In vitro
Guangbin Xia et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
Choosing an animal model for the study of Huntington's disease
Mahmoud A. Pouladi et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
Kirupa Sathasivam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems
Krzysztof Chylinski et al.
RNA BIOLOGY (2013)
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Thomas Gaj et al.
TRENDS IN BIOTECHNOLOGY (2013)
A Transgenic Minipig Model of Huntington's Disease
Monika Baxa et al.
JOURNAL OF HUNTINGTONS DISEASE (2013)
Genetic Correction of Huntington's Disease Phenotypes in Induced Pluripotent Stem Cells
Mahru C. An et al.
CELL STEM CELL (2012)
A Novel BACHD Transgenic Rat Exhibits Characteristic Neuropathological Features of Huntington Disease
Libo Yu-Taeger et al.
JOURNAL OF NEUROSCIENCE (2012)
Huntington's Disease: How Intermediate are Intermediate Repeat Lengths?
Ferdinando Squitieri et al.
MOVEMENT DISORDERS (2012)
A transcription activator-like effector toolbox for genome engineering
Neville E. Sanjana et al.
NATURE PROTOCOLS (2012)
The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity
Stefano Camnasio et al.
NEUROBIOLOGY OF DISEASE (2012)
Modeling Huntington disease in yeast: Perspectives and future directions
Robert P. Mason et al.
Prion (2012)
Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 mice
Mireia Garriga-Canut et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Meganucleases and Other Tools for Targeted Genome Engineering: Perspectives and Challenges for Gene Therapy
George Silva et al.
CURRENT GENE THERAPY (2011)
Neuron-specific proteotoxicity of mutant ataxin-3 in C-elegans: rescue by the DAF-16 and HSF-1 pathways
Andreia Teixeira-Castro et al.
HUMAN MOLECULAR GENETICS (2011)
Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease
Philipp Koch et al.
NATURE (2011)
Monitoring polyglutamine toxicity in yeast
Martin L. Duennwald
METHODS (2011)
Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs
Dongshan Yang et al.
HUMAN MOLECULAR GENETICS (2010)
An ovine transgenic Huntington's disease model
Jessie C. Jacobsen et al.
HUMAN MOLECULAR GENETICS (2010)
Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3
Jana Boy et al.
HUMAN MOLECULAR GENETICS (2009)
Zinc-finger directed double-strand breaks within CAG repeat tracts promote repeat instability in human cells
David Mittelman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
Jens Boch et al.
SCIENCE (2009)
A Simple Cipher Governs DNA Recognition by TAL Effectors
Matthew J. Moscou et al.
SCIENCE (2009)
Disease-specific induced pluripotent stem cells
In-Hyun Park et al.
CELL (2008)
Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease
Sandro Alves et al.
HUMAN MOLECULAR GENETICS (2008)
Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice
Michelle Gray et al.
JOURNAL OF NEUROSCIENCE (2008)
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
Andrea Williams et al.
NATURE CHEMICAL BIOLOGY (2008)
Dominantly inherited ataxias: Lessons learned from Machado Joseph disease/spinocerebellar atria type 3
Henry L. Paulson
SEMINARS IN NEUROLOGY (2007)
Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model
Niclas W. Schiffer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Case of spinocerebellar ataxia type 17 (SCA17) associated with only 41 repeats of the TATA-binding protein (TBP) gene
Ashish Nanda et al.
MOVEMENT DISORDERS (2007)
Highly efficient endogenous human gene correction using designed zinc-finger nucleases
FD Urnov et al.
NATURE (2005)
A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration
D Goti et al.
JOURNAL OF NEUROSCIENCE (2004)
Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis
L Kennedy et al.
HUMAN MOLECULAR GENETICS (2003)
Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats
LB Menalled et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2003)
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
EJ Slow et al.
HUMAN MOLECULAR GENETICS (2003)
Spinocerebellar ataxia 7 (SCA7)
AS Lebre et al.
CYTOGENETIC AND GENOME RESEARCH (2003)
Transgenic mouse models of spinal and bulbar muscular atrophy (SBMA)
M Katsuno et al.
CYTOGENETIC AND GENOME RESEARCH (2003)
Insights into the molecular basis of polyglutamine neurodegeneration from studies of a spinocerebellar ataxia type 7 mouse model
SK Grote et al.
CYTOGENETIC AND GENOME RESEARCH (2003)
Huntingtin toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1
AB Meriin et al.
JOURNAL OF CELL BIOLOGY (2002)
Spinocerebellar ataxia type 1 (SCA1): Phenotype-genotype correlation studies in intermediate alleles
C Zuhlke et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2002)
Altered transcription in yeast expressing expanded polyglutamine
RE Hughes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death
JA Parker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Pathogenic effect of an intermediate-size SCA-6 allele (CAG)19 in a homozygous patient
C Mariotti et al.
NEUROLOGY (2001)
Neurological abnormalities in a knock-in mouse model of Huntington's disease
CH Lin et al.
HUMAN MOLECULAR GENETICS (2001)
The ins and outs of a polyglutamine neurodegenerative disease: Spinocerebellar ataxia type 1 (SCA1)
HT Orr
NEUROBIOLOGY OF DISEASE (2000)
Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans
SH Satyal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins
S Krobitsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Spinocerebellar ataxia type l - Modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice
HB Clark et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human
DP Huynh et al.
NATURE GENETICS (2000)
分享论文
